RxDoctor Payments Data

Raymond Montoya Ii, DPM

Podiatrist · Chicago, ILNPI 1275829954

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,960 of the $6,229 with a category attached, or 63.6%. Medline Industries LP accounts for 65.9% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $3,196 and has fallen 98.6% since, to $44 in 2024.

$6,229in general payments, 2019–2025

Across 62 payments — averaging $100.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medline Industries LP$4K
  • Stryker$689
  • Smith+Nephew$379
  • Organogenesis Inc.$308
  • Musculoskeletal Transplant Foundation Inc.$204
  • KCI USA, Inc.$119
  • plus $428 from 9 others

What the payments were for

  • Consulting fees$3,96064%
  • Speaking & faculty fees$1022%
  • Food & beverage$1,98232%
  • Entertainment$1853%

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,229 in reported general payments places this provider in the 85th percentile of 409 podiatrist providers in Illinois.

See all podiatrist providers in Illinois

Medicare billing

Part B allowed, 2024
$154,269
Medicare patients
727
Services billed
1,467

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate144$2,111
Diclofenac Sodium96$1,970
Ciclopirox55$1,750
Ketoconazole62$1,564
Gabapentin69$685
Colchicine25$643
Imiquimod12$381
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav32$370
Terbinafine Hcl28$250
Methylprednisolone26$123
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen13$96

Paid to pharmacies, not to this prescriber.

Other podiatrist in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →